CCL:NSE-CCL Products (India) Limited (INR)

COMMON STOCK | Packaged Foods | NSE

Last Closing Price

INR 326.30

Change

-3.95 (-1.20)%

Market Cap

INR 43.59B

Volume

0.19M

Avg Analyst Target

INR 560.00 (+71.62%)

Avg User Target

INR
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


CCL Products (India) Limited (CCL) Stock Analysis:
Based on the CCL Products (India) Limited stock forecasts from 1 analysts, the average analyst target price for CCL Products (India) Limited is INR 560.00 over the next 12 months. CCL Products (India) Limited’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of CCL Products (India) Limited is Slightly Bearish, which is based on 4 positive signals and 7 negative signals. At the last closing, CCL Products (India) Limited’s stock price was INR 326.30. CCL Products (India) Limited’s stock price has changed by -5.26% over the past week, -21.51% over the past month and +6.43% over the last year.

About

CCL Products (India) Limited produces, trades, and distributes instant coffee and coffee related products primarily in India. It offers spray dried coffee powder and granules, freeze dried coffee, freeze concentrate liquid coffee, roast and ground coffee, roasted coffee beans, an ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-05-16 )

Largest Industry Peers for Packaged Foods

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NESTLEIND:NSE Nestle India Limited

-184.10 (-1.12%)

INR1,581.50B 73.99 44.84
BRITANNIA:NSE Britannia Industries Limited

+6.40 (+0.20%)

INR791.25B 52.44 32.41
TATACONSUM:NSE TATA CONSUMER PRODUCTS LIMITED

-2.10 (-0.28%)

INR680.01B 88.05 36.80
GSKCONS:NSE GlaxoSmithKline Consumer Healt..

N/A

INR449.84B 38.85 23.89
RUCHI:NSE Ruchi Soya Industries Limited

+60.40 (+6.17%)

INR354.26B 32.66 26.66
HATSUN:NSE Hatsun Agro Product Limited

+36.60 (+4.27%)

INR193.03B 88.57 31.74
ZYDUSWELL:NSE Zydus Wellness Limited

+23.35 (+1.47%)

INR101.01B 32.65 27.77
GAEL:NSE Gujarat Ambuja Exports Limited

+11.75 (+3.83%)

INR71.05B 16.12 8.67
BBTC:NSE Bombay Burmah Trading Corporat..

+7.60 (+0.83%)

INR64.63B 17.02 2.90
AVANTIFEED:NSE Avanti Feeds Limited

-9.50 (-2.07%)

INR62.43B 30.17 14.71

ETFs Containing CCL

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Packaged Foods)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -23.98% 21% F 24% F
Dividend Return 0.70% 67% D+ 46% F
Total Return -23.28% 21% F 25% F
Trailing 12 Months  
Capital Gain 5.50% 59% F 39% F
Dividend Return 1.62% 95% A 69% D+
Total Return 7.11% 59% F 40% F
Trailing 5 Years  
Capital Gain -3.90% 38% F 47% F
Dividend Return 4.56% 78% C+ 60% D-
Total Return 0.66% 38% F 47% F
Average Annual (5 Year Horizon)  
Capital Gain 12.21% 36% F 42% F
Dividend Return 1.02% 76% C 64% D
Total Return 13.24% 36% F 42% F
Risk Return Profile  
Volatility (Standard Deviation) 34.00% 64% D 79% C+
Risk Adjusted Return 38.93% 55% F 60% D-
Market Capitalization 43.59B 73% C 73% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Packaged Foods)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 21.70 65% D 45% F
Price/Book Ratio 3.70 44% F 30% F
Price / Cash Flow Ratio 25.51 46% F 25% F
EV/EBITDA 14.18 65% D 43% F
Management Effectiveness  
Return on Equity 17.40% 65% D 69% D+
Return on Invested Capital 12.89% 59% F 73% C
Return on Assets 9.30% 77% C+ 79% C+
Debt to Equity Ratio 16.27% 41% F 45% F
Technical Ratios  
Dividend Yield 1.51% 86% B 67% D+
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.24 87% B+ 92% A-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (INR)

Quarterly Financials (INR)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector